Pfizer

FDA: COVID Shots Approved For Kids Under 5
Shots could be in toddlers’ arms soon, pending approval from the CDC.
The review by federal health officials was a key step toward a long-awaited decision to begin vaccinating the youngest American children.
“At the end of the day we all want to move fast, but we’ve got to get it right," said White House COVID-19 coordinator Aashish Jha.
Pfizer and partner BioNTech said three COVID-19 shots protect kids under 5.
Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.
A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.
Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
The pharmaceutical company, in making its request, cited a small study that found that children given a booster had a 36-fold increase in virus-fighting antibodies.
This fourth coronavirus vaccine dose would be optional, and federal health officials aren't currently recommending it for everyone in this age group.